PLoS ONE (Jan 2019)

Virtual reality for management of pain in hospitalized patients: A randomized comparative effectiveness trial.

  • Brennan Spiegel,
  • Garth Fuller,
  • Mayra Lopez,
  • Taylor Dupuy,
  • Benjamin Noah,
  • Amber Howard,
  • Michael Albert,
  • Vartan Tashjian,
  • Richard Lam,
  • Joseph Ahn,
  • Francis Dailey,
  • Bradley T Rosen,
  • Mark Vrahas,
  • Milton Little,
  • John Garlich,
  • Eldin Dzubur,
  • Waguih IsHak,
  • Itai Danovitch

DOI
https://doi.org/10.1371/journal.pone.0219115
Journal volume & issue
Vol. 14, no. 8
p. e0219115

Abstract

Read online

ObjectivesTherapeutic virtual reality (VR) has emerged as an effective, drug-free tool for pain management, but there is a lack of randomized, controlled data evaluating its effectiveness in hospitalized patients. We sought to measure the impact of on-demand VR versus "health and wellness" television programming for pain in hospitalized patients.MethodsWe performed a prospective, randomized, comparative effectiveness trial in hospitalized patients with an average pain score of ≥3 out of 10 points. Patients in the experimental group received a library of 21 VR experiences administered using the Samsung Gear Oculus headset; control patients viewed specialized television programming to promote health and wellness. Clinical staff followed usual care; study interventions were not protocolized. The primary outcome was patient-reported pain using a numeric rating scale, as recorded by nursing staff during usual care. Pre- and post-intervention pain scores were compared immediately after initial treatment and after 48- and 72-hours.ResultsThere were 120 subjects (61 VR; 59 control). The mean within-subject difference in immediate pre- and post-intervention pain scores was larger in the VR group (-1.72 points; SD 3.56) than in the control group (-0.46 points; SD 3.01); this difference was significant in favor of VR (P ConclusionsVR significantly reduces pain versus an active control condition in hospitalized patients. VR is most effective for severe pain. Future trials should evaluate standardized order sets that interpose VR as an early non-drug option for analgesia.